JP2001513984A - ヒト核内受容体タンパク質をコードするｄｎａ分子 - Google Patents

ヒト核内受容体タンパク質をコードするｄｎａ分子

Info

Publication number: JP2001513984A
Authority: JP; Japan
Prior art keywords: nnr2; human; nnr1; protein; seq
Prior art date: 1997-08-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2000507693A

Other languages

English (en)

Japanese (ja)

Inventor

チエン，フアン

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-27

Filing date

1998-08-27

Publication date

2001-09-11

1998-08-27 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2001-09-11 Publication of JP2001513984A publication Critical patent/JP2001513984A/ja

Status Pending legal-status Critical Current

Links

241000282414 Homo sapiens Species 0.000 title claims abstract description 198
108020004414 DNA Proteins 0.000 title claims description 89
102000053602 DNA Human genes 0.000 title claims description 40
108020004017 nuclear receptors Proteins 0.000 title abstract description 39
108020005497 Nuclear hormone receptor Proteins 0.000 title abstract description 35
102000007399 Nuclear hormone receptor Human genes 0.000 title abstract 2
238000000034 method Methods 0.000 claims abstract description 53
108090000623 proteins and genes Proteins 0.000 claims description 162
102000004169 proteins and genes Human genes 0.000 claims description 142
239000013604 expression vector Substances 0.000 claims description 62
239000002773 nucleotide Substances 0.000 claims description 47
125000003729 nucleotide group Chemical group 0.000 claims description 47
230000014509 gene expression Effects 0.000 claims description 25
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 22
238000012258 culturing Methods 0.000 claims 8
125000003275 alpha amino acid group Chemical group 0.000 claims 4
239000002299 complementary DNA Substances 0.000 abstract description 77
230000000694 effects Effects 0.000 abstract description 14
238000012216 screening Methods 0.000 abstract description 14
239000013598 vector Substances 0.000 abstract description 13
238000002955 isolation Methods 0.000 abstract description 6
238000012512 characterization method Methods 0.000 abstract description 3
235000018102 proteins Nutrition 0.000 description 91
108020004635 Complementary DNA Proteins 0.000 description 79
238000010804 cDNA synthesis Methods 0.000 description 76
210000004027 cell Anatomy 0.000 description 56
150000001413 amino acids Chemical group 0.000 description 48
239000012634 fragment Substances 0.000 description 40
102000006255 nuclear receptors Human genes 0.000 description 37
150000007523 nucleic acids Chemical class 0.000 description 33
239000013615 primer Substances 0.000 description 28
102000039446 nucleic acids Human genes 0.000 description 24
108020004707 nucleic acids Proteins 0.000 description 24
230000004568 DNA-binding Effects 0.000 description 22
235000001014 amino acid Nutrition 0.000 description 20
108091028043 Nucleic acid sequence Proteins 0.000 description 19
102000005962 receptors Human genes 0.000 description 19
108020003175 receptors Proteins 0.000 description 19
150000001875 compounds Chemical class 0.000 description 18
108020004705 Codon Proteins 0.000 description 17
108700026244 Open Reading Frames Proteins 0.000 description 14
229940024606 amino acid Drugs 0.000 description 14
238000003556 assay Methods 0.000 description 14
230000006870 function Effects 0.000 description 14
230000004927 fusion Effects 0.000 description 13
108090000765 processed proteins & peptides Proteins 0.000 description 13
230000001225 therapeutic effect Effects 0.000 description 13
108020001756 ligand binding domains Proteins 0.000 description 12
230000035772 mutation Effects 0.000 description 12
239000000556 agonist Substances 0.000 description 10
239000005557 antagonist Substances 0.000 description 10
108020004999 messenger RNA Proteins 0.000 description 10
238000012163 sequencing technique Methods 0.000 description 10
238000006467 substitution reaction Methods 0.000 description 10
238000007792 addition Methods 0.000 description 9
238000012217 deletion Methods 0.000 description 9
230000037430 deletion Effects 0.000 description 9
239000003446 ligand Substances 0.000 description 9
102000040430 polynucleotide Human genes 0.000 description 9
108091033319 polynucleotide Proteins 0.000 description 9
239000002157 polynucleotide Substances 0.000 description 9
230000000069 prophylactic effect Effects 0.000 description 9
241000238631 Hexapoda Species 0.000 description 8
239000002671 adjuvant Substances 0.000 description 7
210000004408 hybridoma Anatomy 0.000 description 7
230000003053 immunization Effects 0.000 description 7
238000002649 immunization Methods 0.000 description 7
239000000203 mixture Substances 0.000 description 7
241001465754 Metazoa Species 0.000 description 6
241000699670 Mus sp. Species 0.000 description 6
108091034117 Oligonucleotide Proteins 0.000 description 6
102000037865 fusion proteins Human genes 0.000 description 6
108020001507 fusion proteins Proteins 0.000 description 6
239000013612 plasmid Substances 0.000 description 6
241000894007 species Species 0.000 description 6
241000699666 Mus <mouse, genus> Species 0.000 description 5
238000012408 PCR amplification Methods 0.000 description 5
238000012300 Sequence Analysis Methods 0.000 description 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
230000004071 biological effect Effects 0.000 description 5
238000010367 cloning Methods 0.000 description 5
239000000284 extract Substances 0.000 description 5
102000004196 processed proteins & peptides Human genes 0.000 description 5
239000000047 product Substances 0.000 description 5
239000000126 substance Substances 0.000 description 5
239000003155 DNA primer Substances 0.000 description 4
102000003676 Glucocorticoid Receptors Human genes 0.000 description 4
108090000079 Glucocorticoid Receptors Proteins 0.000 description 4
102000034570 NR1 subfamily Human genes 0.000 description 4
108020001305 NR1 subfamily Proteins 0.000 description 4
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
230000027455 binding Effects 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
238000010276 construction Methods 0.000 description 4
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
239000003814 drug Substances 0.000 description 4
230000002538 fungal effect Effects 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
239000002953 phosphate buffered saline Substances 0.000 description 4
230000002441 reversible effect Effects 0.000 description 4
239000000523 sample Substances 0.000 description 4
238000010561 standard procedure Methods 0.000 description 4
239000000758 substrate Substances 0.000 description 4
230000000699 topical effect Effects 0.000 description 4
241000894006 Bacteria Species 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
101150064767 NNR1 gene Proteins 0.000 description 3
108091005461 Nucleic proteins Chemical group 0.000 description 3
206010035226 Plasma cell myeloma Diseases 0.000 description 3
101100240678 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) NNR2 gene Proteins 0.000 description 3
241000251539 Vertebrata <Metazoa> Species 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
239000000427 antigen Substances 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
210000004899 c-terminal region Anatomy 0.000 description 3
230000011712 cell development Effects 0.000 description 3
230000024245 cell differentiation Effects 0.000 description 3
230000008859 change Effects 0.000 description 3
238000012937 correction Methods 0.000 description 3
238000001514 detection method Methods 0.000 description 3
229940079593 drug Drugs 0.000 description 3
230000001605 fetal effect Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
238000007852 inverse PCR Methods 0.000 description 3
210000004698 lymphocyte Anatomy 0.000 description 3
210000004962 mammalian cell Anatomy 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
201000000050 myeloid neoplasm Diseases 0.000 description 3
229920001184 polypeptide Polymers 0.000 description 3
238000003127 radioimmunoassay Methods 0.000 description 3
229920002477 rna polymer Polymers 0.000 description 3
239000013605 shuttle vector Substances 0.000 description 3
102000005969 steroid hormone receptors Human genes 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
238000013519 translation Methods 0.000 description 3
241001515965 unidentified phage Species 0.000 description 3
IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
239000004475 Arginine Substances 0.000 description 2
206010003445 Ascites Diseases 0.000 description 2
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
101150066516 GST gene Proteins 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
102000005720 Glutathione transferase Human genes 0.000 description 2
108010070675 Glutathione transferase Proteins 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
102000007079 Peptide Fragments Human genes 0.000 description 2
108010033276 Peptide Fragments Proteins 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
241000256251 Spodoptera frugiperda Species 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
241000700605 Viruses Species 0.000 description 2
239000013543 active substance Substances 0.000 description 2
239000008272 agar Substances 0.000 description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
235000009582 asparagine Nutrition 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
239000011324 bead Substances 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000000969 carrier Substances 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
238000011161 development Methods 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
230000029087 digestion Effects 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000001747 exhibiting effect Effects 0.000 description 2
238000009472 formulation Methods 0.000 description 2
125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
230000012010 growth Effects 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
229960004452 methionine Drugs 0.000 description 2
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
210000000287 oocyte Anatomy 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
230000035790 physiological processes and functions Effects 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
210000002307 prostate Anatomy 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
238000002741 site-directed mutagenesis Methods 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
108020003113 steroid hormone receptors Proteins 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
210000001550 testis Anatomy 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
241000701447 unidentified baculovirus Species 0.000 description 2
239000004474 valine Substances 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 description 1
SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 1
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
241000255789 Bombyx mori Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
102100033779 Collagen alpha-4(IV) chain Human genes 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
241000192700 Cyanobacteria Species 0.000 description 1
102000052510 DNA-Binding Proteins Human genes 0.000 description 1
108700020911 DNA-Binding Proteins Proteins 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000710870 Homo sapiens Collagen alpha-4(IV) chain Proteins 0.000 description 1
101000851696 Homo sapiens Steroid hormone receptor ERR2 Proteins 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
108091092724 Noncoding DNA Proteins 0.000 description 1
XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
241000235648 Pichia Species 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
-1 RNA Proteins 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
241000700159 Rattus Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
108010085012 Steroid Receptors Proteins 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
229940123464 Thiazolidinedione Drugs 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
210000001789 adipocyte Anatomy 0.000 description 1
238000005377 adsorption chromatography Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
229940037003 alum Drugs 0.000 description 1
229960003896 aminopterin Drugs 0.000 description 1
230000003321 amplification Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
229940127003 anti-diabetic drug Drugs 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
239000003472 antidiabetic agent Substances 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
239000007640 basal medium Substances 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000009084 cardiovascular function Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
239000012707 chemical precursor Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
239000003636 conditioned culture medium Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
239000012531 culture fluid Substances 0.000 description 1
238000012136 culture method Methods 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
150000001945 cysteines Chemical group 0.000 description 1
239000007933 dermal patch Substances 0.000 description 1
238000013461 design Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000009513 drug distribution Methods 0.000 description 1
239000003596 drug target Substances 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
230000014101 glucose homeostasis Effects 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
239000008187 granular material Substances 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
102000044176 human ESRRB Human genes 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
229910052588 hydroxylapatite Inorganic materials 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
238000010324 immunological assay Methods 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
230000003907 kidney function Effects 0.000 description 1
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
230000003908 liver function Effects 0.000 description 1
125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000006186 oral dosage form Substances 0.000 description 1
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000037452 priming Effects 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
238000003757 reverse transcription PCR Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000013049 sediment Substances 0.000 description 1
238000004062 sedimentation Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
238000001542 size-exclusion chromatography Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
230000003637 steroidlike Effects 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Cell Biology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
High Energy & Nuclear Physics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

JP2000507693A 1997-08-27 1998-08-27 ヒト核内受容体タンパク質をコードするｄｎａ分子 Pending JP2001513984A (ja)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US5709097P	1997-08-27	1997-08-27
US60/057,090		1997-08-27
US6290297P	1997-10-21	1997-10-21
US60/062,902		1997-10-21
US7863398P	1998-03-19	1998-03-19
US60/078,633		1998-03-19
PCT/US1998/017826 WO1999010367A1 (fr)	1997-08-27	1998-08-27	Molecules d'adn codant pour des proteines receptrices nucleaires

Publications (1)

Publication Number	Publication Date
JP2001513984A true JP2001513984A (ja)	2001-09-11

Family

ID=27369158

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2000507693A Pending JP2001513984A (ja)	1997-08-27	1998-08-27	ヒト核内受容体タンパク質をコードするｄｎａ分子

Country Status (4)

Country	Link
EP (1)	EP1007540A4 (fr)
JP (1)	JP2001513984A (fr)
CA (1)	CA2301554A1 (fr)
WO (1)	WO1999010367A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0866127A3 (fr)	1997-03-17	1999-12-22	Smithkline Beecham Plc	HE8AN36, un homologue de récepteur d'hormone stéroide
WO2000042180A1 (fr) *	1999-01-14	2000-07-20	Kyowa Hakko Kogyo Co., Ltd.	Nouvelle proteine
JPWO2003080831A1 (ja) *	2002-03-25	2005-07-28	藤沢薬品工業株式会社	核内受容体ＥＲＲγ３

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5071773A (en) *	1986-10-24	1991-12-10	The Salk Institute For Biological Studies	Hormone receptor-related bioassays

1998
- 1998-08-27 EP EP98943441A patent/EP1007540A4/fr not_active Withdrawn
- 1998-08-27 WO PCT/US1998/017826 patent/WO1999010367A1/fr not_active Application Discontinuation
- 1998-08-27 JP JP2000507693A patent/JP2001513984A/ja active Pending
- 1998-08-27 CA CA002301554A patent/CA2301554A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
EP1007540A1 (fr)	2000-06-14
EP1007540A4 (fr)	2003-06-18
WO1999010367A1 (fr)	1999-03-04
CA2301554A1 (fr)	1999-03-04

Publication	Publication Date	Title
JP4405597B2 (ja)	2010-01-27	ヒト受容体型チロシンキナーゼｋｄｒ
WO1999015660A1 (fr)	1999-04-01	Recepteur hormonal hg38 de glycoproteine couple a la proteine g
JP2001513984A (ja)	2001-09-11	ヒト核内受容体タンパク質をコードするｄｎａ分子
US6054295A (en)	2000-04-25	DNA molecules encoding human nuclear receptor proteins
US7029865B2 (en)	2006-04-18	DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
JP2002508393A (ja)	2002-03-19	ヒト核内受容体タンパク質ｎＮＲ７およびｎＮＲ７−１をコードするＤＮＡ分子
US6693184B1 (en)	2004-02-17	DNA molecules encoding splice variants of the human melanocortin 1 receptor protein
JP2001525197A (ja)	2001-12-11	ヒト核内受容体タンパク質ｎＮＲ５をコードするＤＮＡ分子
US7060463B2 (en)	2006-06-13	DNA molecules encoding Macaca mulatta androgen receptor
JP2001517421A (ja)	2001-10-09	Ｇタンパク質共役糖タンパク質ホルモン受容体ａｏｍｆ０５
US20030119100A1 (en)	2003-06-26	DNA molecules encoding human nuclear receptor proteins
JP2002502240A (ja)	2002-01-22	ヒト脱共役タンパク質３
JP2001525196A (ja)	2001-12-11	脊椎動物核内受容体タンパク質ｎＮＲ４をコードするＤＮＡ分子
US7001742B1 (en)	2006-02-21	Human uncoupling protein 3
JP2001511015A (ja)	2001-08-07	サイクリン依存性プロテインキナーゼ
JP2002530103A (ja)	2002-09-17	Ｇタンパク質共役型受容体ｈｇ５１をコードするｄｎａ分子
JP2004500023A (ja)	2004-01-08	ヒトエンドセリン変換酵素３をコードするｄｎａ分子
JP2002542760A (ja)	2002-12-17	アカゲザルのメラノコルチン３受容体タンパク質をコードするｄｎａ分子